Reactogenicity and Safety of DTPa Vaccine and Haemophilus influenzae Type b Conjugate Vaccine (Hib) in a Single Injection vs DTPw and Hib as Separate Injections as a Booster Vaccination in 18-Month-Old Children

Author： Arístegui J.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.21, Iss.1, 2001-01, pp. : 9-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunogenicity and Reactogenicity following Primary Immunisation with a Combined DTaP-HBV Vaccine and a Haemophilus influenzae Type B Vaccine Administered by Separate or Mixed Injection

By Gabutti G.  

Clinical Drug Investigation, Vol. 25, Iss. 5, 2005-01 ,pp. : 315-323

Adis International

Access to resources Recommend Favorite

DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa™): A Review of its Use as Primary and Booster Vaccination

By Dhillon Sohita  

Drugs, Vol. 70, Iss. 8, 2010-05 ,pp. : 1021-1058

Adis International

Access to resources Recommend Favorite

Hib conjugate vaccine stems Hib disease in The Gambia

By  

Inpharma, Vol. 1, Iss. 1495, 2005-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Booster dose of Hib conjugate vaccine not essential?

By  

Inpharma, Vol. 1, Iss. 1264, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Hib conjugate vaccine reduces disease rates for children in Kenya

By  

Inpharma, Vol. 1, Iss. 1550, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite